KL-6, a Mucin-like Glycoprotein, in Bronchoalveolar Lavage Fluid from Patients with Interstitial Lung Disease
- 1 September 1993
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 148 (3) , 637-642
- https://doi.org/10.1164/ajrccm/148.3.637
Abstract
KL-6, a mucin-like high-molecular-weight glycoprotein, is a serum marker indicating the disease activity of pneumonitis, such as idiopathic pulmonary fibrosis (IPF), hypersensitivity pneumonitis, and sarcoidosis. Immunohistochemical studies have shown that KL-6 is strongly expressed on Type 2 pneumocytes and also exists on epithelial cells in other organs. It has not been clarified whether the increased levels of KL-6 in sera from patients with pneumonitis are derived from the lower respiratory tract. In this study, KL-6 levels were evaluated in bronchoalveolar lavage fluid (BALF) samples from 9 healthy control subjects and 32 patients with interstitial pneumonitis. An abnormally high level of KL-6 in BALF was observed in 70% (7 of 10) of patients with IPF, 64% (9 of 14) of patients with sarcoidosis, and 100% (8 of 8) of patients with hypersensitivity pneumonitis but in none of the healthy control subjects. KL-6 levels in BALF were significantly correlated with numbers of total cells (p < 0.001), lymphocytes (p < 0.001), and neutrophils (p < 0.05) and with concentrations of albumin (p < 0.001) and total protein (p < 0.001) in BALF and, further, with serum KL-6 levels (p < 0.01). These results indicate that increased levels of serum KL-6 in patients with pneumonitis reflect the production levels of KL-6 derived from damaged or regenerating Type 2 pneumocytes in the lower respiratory tract.Keywords
This publication has 27 references indexed in Scilit:
- Monitoring of Serum KL-6 Antigen in a Patient with Radiation PneumoniaChest, 1992
- Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: differences between patients with interstitial lung disease and control subjectsClinical and Experimental Immunology, 1991
- Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome?Thorax, 1990
- Pulmonary gamma interferon production in patients with fibrosing alveolitis.Thorax, 1990
- Bi‐functional action of transforming growth factor‐β on DNA synthesis in early passage human fetal fibroblastsJournal of Cellular Physiology, 1986
- Chronic pulmonary sarcoidosis: relationship between lung lavage cell counts, chest radiograph, and results of standard lung function tests.Thorax, 1985
- Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.Journal of Clinical Investigation, 1981
- Pulmonary SarcoidosisNew England Journal of Medicine, 1981
- Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.Thorax, 1980
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.Journal of Clinical Investigation, 1977